Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping

被引:0
作者
E. Pindurová
A. Žourková
J. Zrůstová
J. Juřica
A. Pavelka
机构
[1] Central European Institute of Technology (CEITEC),Department of Applied Neuroscience, Faculty of Medicine
[2] Masaryk University,Department of Psychiatry, Faculty of Medicine
[3] Faculty Hospital Brno-Bohunice,Department of Medical Genetics
[4] Faculty Hospital Brno,Department of Pharmacology, Faculty of Medicine
[5] Experimental and Applied Neuropsychopharmacology Group,Department of Experimental Biology, Faculty of Science
[6] Central European Institute of Technology (CEITEC),Department of Computer Graphics and Design, Faculty of Informatics
[7] Masaryk University Brno,undefined
[8] Masaryk University,undefined
[9] Masaryk University,undefined
来源
Molecular Biotechnology | 2013年 / 53卷
关键词
High-resolution melting analysis; CYP2D6; Poor metabolizers; SNP; Short amplicon; Melting curve;
D O I
暂无
中图分类号
学科分类号
摘要
High-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons has been described as a fast, cheap, and reliable closed-tube method of genotyping with no need for labeled primers or labeled probes. We adapted this melting analysis assay for the detection of the most common nonfunctional alleles of cytochrome P-450 (CYP) 2D6 in the Caucasian population that affect the metabolism of many commonly used drugs. We used this method to genotype 91 patients under paroxetine therapy. The presence and the constitution of the most common single-nucleotide polymorphisms (1846G>A, 2988G>A, 100C>T, 2549delA, 2615_2617delAAG, and 1707delT) in poor and intermediate metabolizers from the Caucasian population were detected in short amplicons (≤148 bp). After fluorescence normalization, the wild-type, homozygous, and heterozygous samples were easily distinguishable from each other by their specific melting curve shape. A total of 92.6% of the 1846G>A heterozygotes, 96% of the 100C>T heterozygotes, and 100% of the 2988G>A, 2549delA, 2615_2617delAAG, and 1707delT heterozygotes have been correctly distinguished from the wild types. One hundred percent of all the homozygotes in this group of patients have been detected without any error. HRM of short amplicons is a simple tool for effective, rapid, and reliable CYP2D6 genotyping that does not require real-time PCR, labeled probes, processing or any separations after PCR. The reaction is performed in a closed-tube system and is highly specific and sensitive. We proved that this technique is highly reliable for use in routine diagnostics.
引用
收藏
页码:29 / 40
页数:11
相关论文
共 36 条
[31]   The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients [J].
Bienvenu, Emile ;
Swart, Marelize ;
Dandara, Collet ;
Ashton, Michael .
ANTIVIRAL RESEARCH, 2014, 102 :44-53
[32]   Functional RsaI/PstI Polymorphism in Cytochrome P450 2E1 Contributes to Bladder Cancer Susceptibility: Evidence from a Meta-analysis [J].
Deng, Xiao-Dong ;
Gao, Qin ;
Zhang, Bo ;
Zhang, Li-Xia ;
Zhang, Wei ;
Er, Zhe-Er Mu ;
Xie, Ying ;
Ma, Ying ;
Liu, Yun .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (12) :4977-4982
[33]   Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test [J].
Desta, Zeruesenay ;
Modak, Anil ;
Nguyen, Phuong D. ;
Lemler, Suzanne M. ;
Kurogi, Yasuhisa ;
Li, Lang ;
Flockhart, David A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01) :297-305
[34]   Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation [J].
Elmaagacli, A. H. ;
Koldehoff, M. ;
Steckel, N. K. ;
Trenschel, R. ;
Ottinger, H. ;
Beelen, D. W. .
BONE MARROW TRANSPLANTATION, 2007, 40 (07) :659-664
[35]   Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation [J].
A H Elmaagacli ;
M Koldehoff ;
N K Steckel ;
R Trenschel ;
H Ottinger ;
D W Beelen .
Bone Marrow Transplantation, 2007, 40 :659-664
[36]   Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiation [J].
Paul, Sayan ;
Chaudhuri, Tamojit ;
Pant, M. C. ;
Parmar, D. ;
Srivastava, Kirti .
SOUTH ASIAN JOURNAL OF CANCER, 2014, 3 (03) :154-158